BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 27480597)

  • 1. MiR-29a Assists in Preventing the Activation of Human Stellate Cells and Promotes Recovery From Liver Fibrosis in Mice.
    Matsumoto Y; Itami S; Kuroda M; Yoshizato K; Kawada N; Murakami Y
    Mol Ther; 2016 Oct; 24(10):1848-1859. PubMed ID: 27480597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-29a-3p suppresses hepatic fibrosis pathogenesis by modulating hepatic stellate cell proliferation via targeting PIK3R3 gene expression.
    Fu J; Wu B; Zhong S; Deng W; Lin F
    Biochem Biophys Res Commun; 2020 Sep; 529(4):922-929. PubMed ID: 32819600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2.
    Yu F; Chen B; Fan X; Li G; Dong P; Zheng J
    Cell Physiol Biochem; 2017; 43(6):2242-2252. PubMed ID: 29073595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy.
    Chen J; Yu Y; Li S; Liu Y; Zhou S; Cao S; Yin J; Li G
    J Cell Mol Med; 2017 Dec; 21(12):3679-3692. PubMed ID: 28766848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-29a Alleviates Bile Duct Ligation Exacerbation of Hepatic Fibrosis in Mice through Epigenetic Control of Methyltransferases.
    Yang YL; Wang FS; Li SC; Tiao MM; Huang YH
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic Delivery of scAAV8-Encoded MiR-29a Ameliorates Hepatic Fibrosis in Carbon Tetrachloride-Treated Mice.
    Knabel MK; Ramachandran K; Karhadkar S; Hwang HW; Creamer TJ; Chivukula RR; Sheikh F; Clark KR; Torbenson M; Montgomery RA; Cameron AM; Mendell JT; Warren DS
    PLoS One; 2015; 10(4):e0124411. PubMed ID: 25923107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sweroside ameliorated carbon tetrachloride (CCl
    Gong J; Yang F; Yang Q; Tang X; Shu F; Xu L; Wang Z; Yang L
    J Nat Med; 2020 Jan; 74(1):17-25. PubMed ID: 31280460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-29a-3p prevents Schistosoma japonicum-induced liver fibrosis by targeting Roundabout homolog 1 in hepatic stellate cells.
    Kong H; Song Q; Hu W; Guo S; Xiang D; Huang S; Xu X; He J; Pan L; Tao R; Yu H; Huang J
    Parasit Vectors; 2023 Jun; 16(1):184. PubMed ID: 37280619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory Effect of a Human MicroRNA, miR-6133-5p, on the Fibrotic Activity of Hepatic Stellate Cells in Culture.
    Hamada-Tsutsumi S; Onishi M; Matsuura K; Isogawa M; Kawashima K; Sato Y; Tanaka Y
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exogenous Therapeutics of Microrna-29a Attenuates Development of Hepatic Fibrosis in Cholestatic Animal Model through Regulation of Phosphoinositide 3-Kinase p85 Alpha.
    Yang YL; Wang FS; Lin HY; Huang YH
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of miR-483-5p/3p cooperate to inhibit mouse liver fibrosis by suppressing the TGF-β stimulated HSCs in transgenic mice.
    Li F; Ma N; Zhao R; Wu G; Zhang Y; Qiao Y; Han D; Xu Y; Xiang Y; Yan B; Jin J; Lv G; Wang L; Xu C; Gao X; Luo S
    J Cell Mol Med; 2014 Jun; 18(6):966-74. PubMed ID: 24801603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of Mir-29a in Activated Hepatic Stellate Cells Modulates Its Profibrogenic Phenotype through Inhibition of Histone Deacetylases 4.
    Huang YH; Tiao MM; Huang LT; Chuang JH; Kuo KC; Yang YL; Wang FS
    PLoS One; 2015; 10(8):e0136453. PubMed ID: 26305546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-193a/b-3p relieves hepatic fibrosis and restrains proliferation and activation of hepatic stellate cells.
    Ju B; Nie Y; Yang X; Wang X; Li F; Wang M; Wang C; Zhang H
    J Cell Mol Med; 2019 Jun; 23(6):3824-3832. PubMed ID: 30945448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketogenic Diet Enhances the Cholesterol Accumulation in Liver and Augments the Severity of CCl
    Liao YJ; Wang YH; Wu CY; Hsu FY; Chien CY; Lee YC
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNA-122 inhibits hepatic stellate cell proliferation and activation in vitro and represses carbon tetrachloride-induced liver cirrhosis in mice.
    Ma J; Zhao Q; Chen M; Wang W; He B; Jiang Y; Li Y
    Ann Hepatol; 2022; 27(4):100700. PubMed ID: 35338010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
    Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
    J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA-ATB/microRNA-200a/β-catenin regulatory axis involved in the progression of HCV-related hepatic fibrosis.
    Fu N; Zhao SX; Kong LB; Du JH; Ren WG; Han F; Zhang QS; Li WC; Cui P; Wang RQ; Zhang YG; Nan YM
    Gene; 2017 Jun; 618():1-7. PubMed ID: 28302418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-29a is a key regulon that regulates BRD4 and mitigates liver fibrosis in mice by inhibiting hepatic stellate cell activation.
    Huang YH; Kuo HC; Yang YL; Wang FS
    Int J Med Sci; 2019; 16(2):212-220. PubMed ID: 30745801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The histone demethylase KDM4D promotes hepatic fibrogenesis by modulating Toll-like receptor 4 signaling pathway.
    Dong F; Jiang S; Li J; Wang Y; Zhu L; Huang Y; Jiang X; Hu X; Zhou Q; Zhang Z; Bao Z
    EBioMedicine; 2019 Jan; 39():472-483. PubMed ID: 30527625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagy-Related Activation of Hepatic Stellate Cells Reduces Cellular miR-29a by Promoting Its Vesicular Secretion.
    Yu X; Elfimova N; Müller M; Bachurski D; Koitzsch U; Drebber U; Mahabir E; Hansen HP; Friedman SL; Klein S; Dienes HP; Hösel M; Buettner R; Trebicka J; Kondylis V; Mannaerts I; Odenthal M
    Cell Mol Gastroenterol Hepatol; 2022; 13(6):1701-1716. PubMed ID: 35219894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.